AKR1C2 and oropharynx squamous cell carcinoma: This study provides an analysis of the expression and regulation of Aldo-Keto Reductase 1C2 (AKR1C2) in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma (OPSCC).